Category: New products
-
Infographic – VR, AR Yet to Reach Critical Mass
While applications of VR and AR technologies can seem compelling, the numbers of people actually using these systems remain relatively small.
-
Primate Genome A.I. Model IDs Human Disease Variants
A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans.
-
Clinical Trial Begins for Peanut Allergy Treatment
A clinical trial is underway testing an experimental therapy for peanut allergy that its developer says trains the immune system without using peanut proteins.
-
Crispr Therapy Shown to Reduce Harmful Gut Microbes
A clinical trial shows an oral therapy with engineered viruses delivers precise gene-edited payloads to reduce E. coli communities in the gut with no serious adverse effects.
-
Precision T-Cell Solid Tumor Therapy Trial Underway
A clinical trial has begun testing a treatment for solid tumor cancers using engineered T-cells with proteins to attack specific tumor cells, but also avoid healthy cells.
-
AI-Designed Cancer Vaccine Shown to Act Against Melanoma
Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors.
-
Low-Dose Oral Film Reduces Mental Disorder Agitation
Interim results from a clinical trial show a drug given as a dissolvable oral film in a lower dose reduces agitation in people with bipolar disorder and schizophrenia.
-
Safer Forms of Psilocybin Assessed in Preclinical Study
A biotechnology company says it identified engineered precursors of a psychedelic compound that in lab animals produce safe and intended therapeutic effects.
-
$60M Challenge Seeks Biomarkers, Models to Counter Aging Stress
A new challenge competition seeks biomarkers, models, and clinical tests of the factors behind responses to stress conditions in human aging that can stave off frailty or death.
-
Brain-Computer Device Company Gains $33M in Early Funds
A company creating brain-computer interface devices to help people with disabling communications impairments is raising $33 million in its first venture round.